Masculinizing Testosterone Therapy Reduces the Incidence of PIK3CA-Mutant/ER⁺ Breast Cancer but Not BRCA1-Associated Triple-Negative Breast Cancer.
Wang L, Sardella BR, Thavamani A, Massicott ES, Bret-Mounet VC, Baker GM, Guzman-Arocho YD, Tobias AM, Bartlett RA, Aronson EK, Vandal SR, Liu Z, Lee J, Veta M, Wetstein SC, Aung STH, Lui ML, Cato K, Rohde CH, Gardner KL, Hibshoosh H, Bockting WO, Houghton LC, Charlton BM, Berwick SA, Smart AC, Tesch ME, Medford AJ, Peterson CW, Domogauer JD, Jia L, Clohessy JG, Tung NM, Wulf GM, Heng YJ.
Wang L, et al. Among authors: smart ac.
medRxiv [Preprint]. 2025 Sep 19:2025.09.15.25335324. doi: 10.1101/2025.09.15.25335324.
medRxiv. 2025.
PMID: 41001463
Free PMC article.
Preprint.